COVID-19 Impact on Organ Preservation Market By Key Manufacturers, By Solution (University of Wisconsin (UW), Custodial HTK, Perfadex, Others (Celsior & Euro-Collins)), By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By organ type (Kidneys, Liver, Lung, Heart, Others (Intestine & Pancreas)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Report ID: 392052 | May 2020 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
Global Organ Preservation Market size is estimated to record USD 341.67 Million by 2026, at a Compound Annual Growth Rate (CAGR) of 6.7%.

Organ Preservation Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 217 Million in 2019.

The market report includes Organ Preservation market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Organ Preservation Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Organ Preservation Market Competitive Landscape
The key companies in Organ Preservation Market are Paragonix technologies, XVIVO Perfusion, Dr. Franz Köhler Chemie GMBH, Essential pharmaceuticals, Transmedics, Inc, Organox limited, 21st Century Medicine, Shanghai Genext Medical Technology, Bridge to life-limited, Waters medical systems, Preservation solutions, Carnamedica.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis

Chapter 5. Organ Preservation Industry, By Solution
5.1. Organ Preservation Market, By Solution 2019-2026
5.2. University of Wisconsin (UW)
5.3. Custodial HTK
5.4. Perfadex
5.5. Others

Chapter 6. Organ Preservation Industry, By Technique
6.1. Organ Preservation Market, By Technique 2019-2026
6.2. Static Cold Storage
6.3. Hypothermic Machine Perfusion
6.4. Normothermic Machine Perfusion

Chapter 7. Organ Preservation Industry, By Organ Type
7.1. Organ Preservation Market, By Organ Type 2019-2026
7.2. Kidneys
7.3. Liver
7.4. Lung
7.5. Heart
7.6. Others

Chapter 8. Organ Preservation Industry, By Region
8.1. Organ Preservation Market, By Region 2019-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.1. Canada
8.1.1.2. Mexico
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC

Chapter 9. Competitive Landscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis

Chapter 10. Company Profiles
10.1. Paragonix technologies
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. XVIVO Perfusion
10.3. Dr. Franz Köhler Chemie GMBH
10.4. Essential pharmaceuticals
10.5. Transmedics, Inc
10.6. Organox limited
10.7. 21st Century Medicine
10.8. Shanghai Genext Medical Technology
10.9. Bridge to life-limited
10.10. Waters medical systems
10.11. Preservation solutions
10.12. Carnamedica

Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
11.3. Disclaimer
1. Paragonix technologies
2. XVIVO Perfusion
3. Dr. Franz Köhler Chemie GMBH
4. Essential pharmaceuticals
5. Transmedics, Inc
6. Organox limited
7. 21st Century Medicine
8. Shanghai Genext Medical Technology
9. Bridge to life-limited
10. Waters medical systems
11. Preservation solutions
12. Carnamedica

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404